Contact Information: Contact: Dino Luzzi CEO Medivisor, Inc. Tel: 631.549.7100
Medivisor, Inc. Set to Launch 'Maximum Energy Shot'
| Source: Medivisor, Inc.
HUNTINGTON STATION, NY--(Marketwire - October 9, 2008) - Medivisor, Inc. (PINKSHEETS : MVSR ),
developer of next-generation focus driven marketing tools, announced today
that it is in its final stages of pre-production of its proprietary drink,
Maximum Energy Shot. Packaging and labeling should be completed by the end
of the week, with production and national distribution to commence shortly.
As previously announced this product will target both the United States and
European markets. According to Market Research Group, the energy drink
category has grown by 440% since 2002 to a whopping $6.6 billion in 2007
and is expected to reach $9 billion in 2011.
"We are anxiously awaiting the official launch of Medivisor's beverage,
Maximum Energy Shot," stated Dino Luzzi, CEO of Medivisor, Inc. "We
anticipate that the product will be available for viewing and purchase on
the company's web site shortly," Mr. Luzzi added.
About Medivisor, Inc.:
Medivisor, Inc. is a developer of next-generation focus driven marketing
tools, dedicated to providing technologies that offer innovative and
competitive advantages to the bioscience and pharmaceutical markets. From
pre-product development through product launch and commercialization,
Medivisor offers worldwide experience in delivering effective and
successful integrated marketing and creative communications campaigns for
the benefit of its clients.
Safe Harbor
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 (the "Act")
Additionally, words such as "seek," "intend," "believe," "plan,"
"estimate," "expect," "anticipate" and other similar expressions are
forward-looking statements within the meaning of the Act. Some or all of
the events or results anticipated by these forward-looking statements may
not occur. Further information on Medivisor risk factors is contained in
its filings with the Securities and Exchange Commission. Medivisor does not
undertake any duty nor does it intend to update the results of these
forward-looking statements.